Abstract:Objective: To investigate the protective efficacy of miR-155 on down regulating NoxA1 gene expression, resulting in an inhibitory effect of vascular smooth muscle cell (VSMC) over proliferation and thus alleviating the progression of coronary artery atherosclerosis in mouse disease model. Methods: Carotid artery of C57BL6 mouse was used for VSMC primary culture. The isolated VSMC was transfected with recombinant Pad2YFG adenovirus fluorescent vector with miR-155 fragment (mimic or mutant). Fluorescence microscope was applied to observe the transfection rate of miR-155 into VSMC. Artificial artery-injured mouse model fed with high-fat diet was established as host to accept VSMC transplantation via tail vein injection for 3 consecutive days. Aortic and carotid arteries were extracted at week 6. Distribution of miR-155 was quantified; protein and RNA were extracted to detect NoxA1 and NADPH expression in vehicle control, miR-155 mimic group, and the inhibitor group. Immunohistochemistry was performed in arteries section to compare the thickness of neointima and assess the severity of AS of each group. Results: The miR-155 distribution was observed varied at week 6 in control, miR-155 mimic and inhibitor groups. The NoxA1 protein expression in VSMC was decreased in mimic group at week 6 vs control and inhibitor groups (p<0.05); no significant difference of NADPH expression was observed in all groups. The NoxA1 and NADPH gene expression in VSMC were both found reduced compared with those of control group at week 6 (p<0.05). Immunohistochemistry of artery frozen sections figured out that the thickness of neointima of carotid artery in miR-155 mimic group was significantly lower vs control and inhibitor groups (p<0.01) at week 6. Conclusion: miR-155 transfection into VSMC seems to have reversed regulatory effect on NoxA1 expression resulting in amelioration of atherosclerotic lesion in artificial AS mouse model. A therapeutic strategy based on the functional role of miR-155 in VSMC over proliferation-based atherosclerosis would need to complementarily-synthesize miRNAs, which is a promising therapeutic tool due to the enhanced stability and sustained effects after intravenous injection in the arterial wall.

Interfering Microrna-410 Attenuates Atherosclerosis Via the HDAC1/KLF5/IKBα/NF-κB Axis

Microrna-181A Represses Ox-Ldl-stimulated Inflammatory Response in Dendritic Cell by Targeting C-Fos

Abstract 8510: Regulation of Microrna-155 of the Atherosclerotic Inflammatory Responses by Targeting Map3k10

Regulation of Microrna-155 in Atherosclerotic Inflammatory Responses by Targeting Map3k10

LncRNA HOTAIR Inhibits miR-19a-3p to Alleviate Foam Cell Formation and Inflammatory Response in Atherosclerosis

MicroRNA-181a-5p and microRNA-181a-3p cooperatively restrict vascular inflammation and atherosclerosis

Silencing of OIP5-AS1 Protects Endothelial Cells from Ox-Ldl-triggered Injury by Regulating KLF5 Expression Via Sponging Mir-135A-5p.

Mir-223 Inhibits Lipid Deposition And Inflammation By Suppressing Toll-Like Receptor 4 Signaling In Macrophages

Abstract 237: the Inhibitory Effect on Vascular Smooth Muscle Cell Hyperplasia in Artificial Atherosclerotic Mouse Model Via Mir-155 Induced NoxA1 Down Regulation

miR‐141‐5p suppresses vascular smooth muscle cell inflammation, proliferation, and migration via inhibiting the HMGB1/NF‐κB pathway

Microrna‐107 Protects Against Inflammation and Endoplasmic Reticulum Stress of Vascular Endothelial Cells Via KRT1‐dependent Notch Signaling Pathway in a Mouse Model of Coronary Atherosclerosis

Microrna-181A is Upregulated in Human Atherosclerosis Plaques and Involves in the Oxidative Stress-Induced Endothelial Cell Dysfunction Through Direct Targeting Bcl-2.

Suppression of microRNA-155 exerts an anti-inflammatory effect on CD4+ T cell-mediated inflammatory response in the pathogenesis of atherosclerosis

Elevated MicroRNA-155 Targets HBP1 to Promote the Formation of Macrophage-Derived Foam Cell and This Can Be Effectively Suppressed by YY1/HDACs Complex

Mir-140a Contributes To The Pro-Atherosclerotic Phenotype Of Macrophages By Downregulating Interleukin-10

miR-155 in the Resolution of Atherosclerosis

HDAC1 promotes artery injury through activation of VAV3 by binding to miR-182-5p in atherosclerotic mice model

MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models Through the JAK1/STAT Signaling Pathway

Elevated Microrna-155 Promotes Foam Cell Formation By Targeting Hbp1 In Atherogenesis

Silenced long non-coding RNA activated by DNA damage elevates microRNA-495-3p to suppress atherosclerotic plaque formation via reducing Krüppel-like factor 5

MicroRNA-19b/221/222 Induces Endothelial Cell Dysfunction Via Suppression of PGC-1α in the Progression of Atherosclerosis